| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 148133-82-8 | 4-Methylenepiperidine | C6H11N |
| 148146-51-4 | 3-(4-Fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyl-2-oxiranecarboxamide | C26H22FNO4 |
| 148152-63-0 | Napitane | C22H25NO2 |
| 148209-29-4 | 3,3'-Diamino-4,4'-difluorobenzophenone | C13H10F2N2O |
| 148214-62-4 | 2-Methoxy-1H-pyrrolo[2,3-d]pyrimidine | C7H7N3O |
| 148214-90-8 | trans-3-Amino-1-Boc-4-hydroxypyrrolidine | C9H18N2O3 |
| 148215-77-4 | 2-(Cyclopentyloxy)benzoic acid | C12H14O3 |
| 148217-40-7 | (betaR,deltaR,3R)-5-(4-Fluorophenyl)-2,3-dihydro-beta,delta-dihydroxy-3-(1-methylethyl)-2-oxo-4-phenyl-3-[(phenylamino)carbonyl]-1H-Pyrrole-1-heptanoic acid sodium salt (1:1) | C33H34FN2O6.Na |
| 148218-14-8 | Doxorubicin EP Impurity B HBr | C29H35Br2NO11 |
| 148218-19-3 | (-)-O-Desmethyltramadol hydrochloride | C15H23NO2.HCl |
| 148229-78-1 | (+)-Tramadol hydrochloride | C16H25NO2.HCl |
| 148240-65-7 | (1S,2S)-1,2-Bis(2-methoxyphenyl)ethane-1,2-diamine | C16H20N2O2 |
| 148244-82-0 | Seco-isolariciresinol diglucoside | C32H46O16 |
| 148245-77-6 | 1'''-O-beta-D-Glucopyranosylformoside | C31H42O17 |
| 148254-21-1 | N,N-Bis(1-methylethyl)phosphoramidous acid 6-[[6-[bis(4-methoxyphenyl)phenylmethoxy]hexyl]dithio]hexyl 2-cyanoethyl ester | C42H61N2O5PS2 |
| 148254-32-4 | 5-Bromo-2-chloro-4-fluoro-phenol | C6H3BrClFO |
| 148256-63-7 | 2,5-Dibromo-3-dodecylthiophene | C16H26Br2S |
| 148256-82-0 | 4-Chloro-2-(methylthio)pyrimidine-5-carboxaldehyde | C6H5ClN2OS |
| 148262-19-5 | TOP-53 (free base) | C28H36N2O7 |
| 148262-77-5 | (+)-O-Desmethyl Tramadol hydrochloride | C15H23NO2.HCl |
| 148296-46-2 | Guanosine 5'-(trihydrogen diphosphate) P'-alpha-D-mannopyranosyl ester disodium salt | C16H23N5O16P2Na2 |
| 148296-47-3 | Guanosine 5'-diphospho-beta-L-fucose sodium salt | C16H23N5Na2O15P2 |
| 148330-12-5 | Brain injury-derived neurotrophic peptide | C62H102N18O18 |
| 148332-36-9 | [2,2':6',2''-Terpyridine]-4'-carboxylic acid | C16H11N3O2 |
| 148337-11-5 | N-[N2-[N-[N2-[N-[N-[N-[N-[N-(N-L-Threonyl-L-seryl)-L-seryl]-L-isoleucyl]-L-alpha-glutamyl]-L-phenylalanyl]-L-alanyl]-L-arginyl]-L-leucyl]-L-glutaminyl]-L-phenylalanine | C59H91N15O18 |
| 148344-28-9 | 4-Amino-3-nitro-benzenecarboximidamide | C7H8N4O2 |
| 148345-64-6 | 2-Ethoxy-1-naphthaleneboronic acid | C12H13BO3 |
| 148348-15-6 | Fibroblast growth factor 7 | |
| 148356-14-3 | 8-Fluoro-2,4(1H,3H)-quinolinedione | C9H6FNO2 |
| 148369-91-9 | (S)-Daipen | C19H26N2O2 |
| 148380-55-6 | alpha-(Acetyloxy)thymidine | C12H16N2O7 |
| 148383-51-1 | Dipalmitoyl L-alpha-phosphatidylcholine monohydrate | C40H80NO8P.H2O |
| 148404-28-8 | 5-Oxohexahydrocyclopenta[c]pyrrole-2-carboxylic acid tert-butyl ester | C12H19NO3 |
| 148404-29-9 | Hexahydro-5-oxocyclopenta[c]pyrrole-2(1H)-carboxylic acid benzyl ester | C15H17NO3 |
| 148406-13-7 | 2-Chloro-5-(chloromethyl)pyrimidine | C5H4Cl2N2 |
| 148408-66-6 | Docetaxel trihydrate | C43H53NO14.3(H2O) |
| 148409-20-5 | (9Z,17S)-17-[[6-O-Acetyl-2-O-(6-O-acetyl-beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy]-9-octadecenoic acid intramol. 1,4''-ester | C34H56O14 |
| 148409-36-3 | (+)-Matairesinol | C20H22O6 |
| 148411-57-8 | Chitosan lactate (ester) | |
| 148416-38-0 | 2,3,4-Trifluoro-6-nitroaniline | C6H3F3N2O2 |
| 148438-00-0 | Methyl 3-(trifluoromethoxy)benzoate | C9H7F3O3 |
| 148439-49-0 | 106-126-Prion protein (human) | C80H138N26O24S2 |
| 148459-00-1 | 4-(Bromomethyl)-N-methylbenzenesulfonamide | C8H10BrNO2S |
| 148459-54-5 | 4-Amino-3-methoxyphenylmethanol | C8H11NO2 |
| 148461-14-7 | (4S)-2-(2-(Diphenylphosphino)phenyl)-4-isopropyl-4,5-dihydrooxazole | C24H24NOP |
| 148461-16-9 | (4S)-4-(1,1-Dimethylethyl)-2-[2-(diphenylphosphino)phenyl]-4,5-dihydrooxazole | C25H26NOP |
| 148462-57-1 | 1-Methoxy-2-propyl propanoate | C7H14O3 |
| 148465-45-6 | Crofelemer | |
| 148471-91-4 | Hematoporphyrin monomethyl ether | C35H40N4O6 |
| 148477-71-8 | Spirodiclofen | C21H24Cl2O4 |